GO:0005922 connexin complex: assembly and research

The connexin complex, annotated as GO:0005922, is a cellular component defined as an assembly of six connexin molecules that is made in the Golgi apparatus and subsequently transported to the plasma membrane, where docking of two connexons on apposed plasma membranes across the extracellular space forms a gap junction. This hexameric hemichannel is also known as a connexon, and its regulated assembly and trafficking are essential for intercellular communication in virtually all tissues. Because connexin complexes directly connect the cytoplasm of neighboring cells, they coordinate electrical activity, metabolite sharing, and signaling gradients that cannot be reproduced by soluble factors alone. Researchers study GO:0005922 because its dysfunction is linked to a broad spectrum of human disorders. Mutations in connexin genes underlie non-syndromic autosomal-dominant deafness and palmoplantar keratodermas, while altered connexin expression contributes to atherosclerosis and glioblastoma progression [1,3,4,8]. In the nervous system, connexin-mediated coupling in satellite glial cells has been shown to sustain nociceptive hypersensitivity, identifying the connexin complex as a potential analgesic target. These findings make the connexin complex a high-value node for mechanistic, genetic, and pharmacological investigation [2,5]. Understanding the connexin complex requires integrating structural biology, trafficking assays, and functional readouts of gap junctional intercellular communication. The QuickGO definition emphasizes both the biosynthetic origin in the Golgi and the final docked state at the plasma membrane, so experimental models must capture assembly, transport, and channel function. This article summarizes the ontology, core biology, disease links, and CRISPR-based research strategies for GO:0005922, with all claims grounded in published literature [1,2,3,4,5,6,7,8].

In simple terms, the connexin complex is a six-part protein channel that cells build inside the Golgi and then ship to the cell surface, where it pairs with an identical channel on a neighboring cell to form a gap junction. According to the QuickGO definition, GO:0005922 describes an assembly of six connexin molecules made in the Golgi apparatus and subsequently transported to the plasma membrane, where docking of two connexons on apposed plasma membranes across the extracellular space forms a gap junction. The term is synonymous with connexon and connexon complex, and it is classified under the cellular_component ontology aspect. Functionally, the connexin complex is a hemichannel that becomes a complete intercellular channel only upon docking with a partner connexon, enabling direct cytoplasmic continuity between adjacent cells.

The connexin complex is important because it is the fundamental structural unit of gap junctions, which provide direct cytoplasmic communication between adjacent cells and coordinate electrical and metabolic signals in tissues ranging from the heart and vasculature to the inner ear and nervous system. Disruption of connexin complex assembly, trafficking, or docking has been linked to inherited and acquired human diseases, including non-syndromic autosomal-dominant deafness, palmoplantar keratodermas, atherosclerosis, and glioblastoma [1,3,4,8]. In addition, connexin-mediated coupling in satellite glial cells contributes to nociceptive hypersensitivity, highlighting the connexin complex as a target for pain research. Because connexin complexes are assembled in the Golgi and function at the plasma membrane, they also serve as a model system for studying membrane protein trafficking and channel assembly. For researchers, GO:0005922 therefore connects cell biology, genetics, and translational disease studies [2,5,7].

The following genes and proteins are central to the biology, regulation, and disease relevance of the connexin complex (GO:0005922).

The connexin complex is regulated at multiple levels, including connexin gene expression, oligomerization in the Golgi, trafficking to the plasma membrane, and docking at the cell surface. Connexin expression and function can be altered in disease contexts such as atherosclerosis, where changes in connexin-mediated communication contribute to vascular pathology [4,5]. In glioblastoma, connexin-Pannexin duality influences channel activity and tumor biology. In the cochlea, connexin-26 interactions with membrane proteins functionally relevant to hearing modulate connexin complex behavior. In satellite glial cells, reduced connexin-mediated coupling has been linked to resolution of nociceptive hypersensitivity, indicating that coupling strength is dynamically regulated.

Mutations in connexin genes that form connexin complexes cause non-syndromic autosomal-dominant deafness and palmoplantar keratodermas [1,8]. Connexin-26 interactions with membrane proteins functionally relevant to the cochlea further support the importance of connexin complex integrity for hearing. These disorders illustrate how single-gene defects in connexin complex components can produce tissue-specific pathology [1,8].

Connexins and their complexes contribute to the pathogenesis of atherosclerosis by influencing cell-to-cell communication in the vessel wall [4,5]. Altered connexin expression and gap junctional coupling are observed in atherosclerotic lesions and are thought to affect endothelial and smooth muscle cell behavior [4,5]. Research on connexin complexes in atherosclerosis aims to define how gap junctional communication modulates vascular disease progression [4,5].

In glioblastoma, connexin and Pannexin channels exhibit functional duality that influences tumor cell communication and survival. This duality highlights the complexity of targeting connexin complexes in cancer, where both gap junctional and hemichannel activities may contribute to disease. Understanding connexin complex biology in glioblastoma is an active area of research.

Connexin-mediated coupling in satellite glial cells contributes to nociceptive hypersensitivity, and reducing this coupling can resolve hypersensitivity. This finding links the connexin complex to sensory signaling and identifies it as a potential target for pain management. The study of connexin complexes in glial cells is therefore relevant to chronic pain research.

CRISPR knockout, point mutation, knock-in, and overexpression enable precise manipulation of connexin genes to test their role in connexin complex assembly and function. These approaches are essential for linking specific connexin variants to disease phenotypes such as deafness and skin disorders [1,8]. Library screening can identify modifiers of connexin complex biology in an unbiased manner.

Fluorescence imaging of tagged connexins allows visualization of connexin complex assembly in the Golgi and trafficking to the plasma membrane. Docking of connexons at cell-cell contacts can be assessed by localization studies at apposed membranes. These methods directly test the steps described in the QuickGO definition of GO:0005922.

Dye transfer and electrophysiological assays measure intercellular communication through docked connexin complexes. These functional readouts are used to determine whether genetic perturbations alter gap junctional coupling. Such assays are relevant to disease models including atherosclerosis and chronic pain [4,6].

Proteomic approaches can identify proteins that interact with connexin complexes and regulate their function. For example, connexin-26 interactions with membrane proteins functionally relevant to the cochlea have been studied to understand hearing biology. Interaction studies complement genetic models by revealing the molecular context of connexin complexes.

Researchers studying connexin complex-related genes often need to determine whether a candidate gene is causally involved in gap junction assembly, trafficking, or disease. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point mutation, knock-in, and overexpression of connexin genes, as well as library screening and bioinformatics support to accelerate functional genomics of GO:0005922.

The connexin complex (GO:0005922) is a hexameric assembly of six connexin proteins that is built in the Golgi, delivered to the plasma membrane, and docked with a partner connexon to form a gap junction. Its central role in intercellular communication makes it essential for tissue homeostasis and a key contributor to diseases including deafness, palmoplantar keratodermas, atherosclerosis, glioblastoma, and chronic pain [1,3,4,6,8]. Continued research using CRISPR-based models and functional assays will clarify how connexin complexes are regulated and how they can be targeted therapeutically [2,5,7].